Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defining treatment refractoriness in schizophrenia.

H Y Meltzer1

  • 1Dept. of Psychiatry, University Hospital, Cleveland, OH 44106.

Schizophrenia Bulletin
|January 1, 1990
PubMed
Summary

Defining treatment resistance for clozapine (a medication for schizophrenia) needs careful consideration. A broader definition could improve patient care and pave the way for safer, next-generation antipsychotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.

Journal of neurochemistry·1996
Same author

Genetic variation of 5-HT2A receptor and response to clozapine.

Lancet (London, England)·1995
Same author

Association study between the dopamine D4 receptor gene and schizophrenia.

American journal of medical genetics·1995
Same author

Neuropeptide Y in frontal cortex is not altered in major depression.

Journal of neurochemistry·1995
Same author

Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men.

Biological psychiatry·1995
Same author

Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia.

Archives of general psychiatry·1995

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Clozapine is a vital antipsychotic for treatment-resistant schizophrenia.
  • Its use is limited by the risk of agranulocytosis, a serious blood disorder.
  • Current criteria for treatment refractoriness are stringent.

Purpose of the Study:

  • To propose a more liberal definition of treatment refractoriness for clozapine.
  • To highlight the limitations of existing therapies.
  • To facilitate the transition to novel antipsychotics without agranulocytosis risk.

Main Methods:

  • Conceptual analysis of treatment refractoriness criteria.
  • Review of clozapine's efficacy and safety profile.
  • Exploration of future antipsychotic development.

Main Results:

  • Current high-level criteria for clozapine refractoriness may underestimate treatment limitations.
  • A more inclusive definition is needed to guide therapeutic decisions.
  • Failure to achieve best premorbid functioning is a potential indicator.

Conclusions:

  • Revising treatment refractoriness criteria is crucial for optimizing schizophrenia management.
  • A liberalized definition supports the timely consideration of alternative treatments.
  • This approach aids in the development and adoption of next-generation antipsychotics.

Related Experiment Videos